120 related articles for article (PubMed ID: 25396343)
21. [Primary immunodeficiency diseases].
Futatani T; Kanegane H; Miyawaki T
Nihon Rinsho; 2005 May; 63 Suppl 5():559-64. PubMed ID: 15954409
[No Abstract] [Full Text] [Related]
22. Interleukin-32α production is regulated by MyD88-dependent and independent pathways in IL-1β-stimulated human alveolar epithelial cells.
Ko NY; Mun SH; Lee SH; Kim JW; Kim DK; Kim HS; Her E; Kim SH; Won HS; Shin HS; Kim HS; Kim YM; Choi WS
Immunobiology; 2011; 216(1-2):32-40. PubMed ID: 20430472
[TBL] [Abstract][Full Text] [Related]
23. Inherited human IRAK-4 deficiency: an update.
Picard C; von Bernuth H; Ku CL; Yang K; Puel A; Casanova JL
Immunol Res; 2007; 38(1-3):347-52. PubMed ID: 17917042
[TBL] [Abstract][Full Text] [Related]
24. Self-reactive VH4-34-expressing IgG B cells recognize commensal bacteria.
Schickel JN; Glauzy S; Ng YS; Chamberlain N; Massad C; Isnardi I; Katz N; Uzel G; Holland SM; Picard C; Puel A; Casanova JL; Meffre E
J Exp Med; 2017 Jul; 214(7):1991-2003. PubMed ID: 28500047
[TBL] [Abstract][Full Text] [Related]
25. PID in Disguise: Molecular Diagnosis of IRAK-4 Deficiency in an Adult Previously Misdiagnosed With Autosomal Dominant Hyper IgE Syndrome.
Frans G; Moens L; Schrijvers R; Wuyts G; Bouckaert B; Schaballie H; Dupont L; Bossuyt X; Corveleyn A; Meyts I
J Clin Immunol; 2015 Nov; 35(8):739-44. PubMed ID: 26472314
[TBL] [Abstract][Full Text] [Related]
26. Inherited disorders of human Toll-like receptor signaling: immunological implications.
Ku CL; Yang K; Bustamante J; Puel A; von Bernuth H; Santos OF; Lawrence T; Chang HH; Al-Mousa H; Picard C; Casanova JL
Immunol Rev; 2005 Feb; 203():10-20. PubMed ID: 15661018
[TBL] [Abstract][Full Text] [Related]
27. Detection of MYD88 L265P and WHIM-like CXCR4 mutation in patients with IgM monoclonal gammopathy related disease.
Cao XX; Meng Q; Cai H; He TH; Zhang CL; Su W; Sun J; Li Y; Xu W; Zhou DB; Li J
Ann Hematol; 2017 Jun; 96(6):971-976. PubMed ID: 28280994
[TBL] [Abstract][Full Text] [Related]
28. Human tyk2 kinase deficiency: another primary immunodeficiency syndrome.
Watford WT; O'Shea JJ
Immunity; 2006 Nov; 25(5):695-7. PubMed ID: 17098200
[TBL] [Abstract][Full Text] [Related]
29. MyD88-induced downregulation of IRAK-4 and its structural requirements.
Hatao F; Yamamoto M; Muroi M; Kaminishi M; Tanamoto K
FEMS Immunol Med Microbiol; 2008 Jul; 53(2):260-4. PubMed ID: 18503546
[TBL] [Abstract][Full Text] [Related]
30. MyD88, IRAK1 and TRAF6 knockdown in human chondrocytes inhibits interleukin-1-induced matrix metalloproteinase-13 gene expression and promoter activity by impairing MAP kinase activation.
Ahmad R; Sylvester J; Zafarullah M
Cell Signal; 2007 Dec; 19(12):2549-57. PubMed ID: 17905570
[TBL] [Abstract][Full Text] [Related]
31. Selective interleukin-1 receptor-associated kinase 4 inhibitors for the treatment of autoimmune disorders and lymphoid malignancy.
Kelly PN; Romero DL; Yang Y; Shaffer AL; Chaudhary D; Robinson S; Miao W; Rui L; Westlin WF; Kapeller R; Staudt LM
J Exp Med; 2015 Dec; 212(13):2189-201. PubMed ID: 26621451
[TBL] [Abstract][Full Text] [Related]
32. Toll-like receptors and their adaptors are regulated in macrophages after phagocytosis of lipopolysaccharide-coated titanium particles.
Hirayama T; Tamaki Y; Takakubo Y; Iwazaki K; Sasaki K; Ogino T; Goodman SB; Konttinen YT; Takagi M
J Orthop Res; 2011 Jul; 29(7):984-92. PubMed ID: 21308757
[TBL] [Abstract][Full Text] [Related]
33. IRAK4 and NEMO mutations in otherwise healthy children with recurrent invasive pneumococcal disease.
Ku CL; Picard C; Erdös M; Jeurissen A; Bustamante J; Puel A; von Bernuth H; Filipe-Santos O; Chang HH; Lawrence T; Raes M; Maródi L; Bossuyt X; Casanova JL
J Med Genet; 2007 Jan; 44(1):16-23. PubMed ID: 16950813
[TBL] [Abstract][Full Text] [Related]
34. Interleukin 1 receptor-associated kinase 1 (IRAK1) mutation is a common, essential driver for Kaposi sarcoma herpesvirus lymphoma.
Yang D; Chen W; Xiong J; Sherrod CJ; Henry DH; Dittmer DP
Proc Natl Acad Sci U S A; 2014 Nov; 111(44):E4762-8. PubMed ID: 25341731
[TBL] [Abstract][Full Text] [Related]
35. Interleukin receptor-associated kinase-4 deficiency impairs Toll-like receptor-dependent innate antiviral immune responses.
McDonald DR; Brown D; Bonilla FA; Geha RS
J Allergy Clin Immunol; 2006 Dec; 118(6):1357-62. PubMed ID: 17157666
[TBL] [Abstract][Full Text] [Related]
36. Recipient Myd88 Deficiency Promotes Spontaneous Resolution of Kidney Allograft Rejection.
Lerret NM; Li T; Wang JJ; Kang HK; Wang S; Wang X; Jie C; Kanwar YS; Abecassis MM; Luo X; Zhang Z
J Am Soc Nephrol; 2015 Nov; 26(11):2753-64. PubMed ID: 25788530
[TBL] [Abstract][Full Text] [Related]
37. Heritable defects of the human TLR signalling pathways.
Puel A; Yang K; Ku CL; von Bernuth H; Bustamante J; Santos OF; Lawrence T; Chang HH; Al-Mousa H; Picard C; Casanova JL
J Endotoxin Res; 2005; 11(4):220-4. PubMed ID: 16176658
[TBL] [Abstract][Full Text] [Related]
38. Characterization of the interleukin 1 receptor-associated kinase 4 (IRAK4)-encoding gene in salmonid fish: the functional copy is rearranged in Oncorhynchus mykiss and that factor can impair TLR signaling in mammalian cells.
Brietzke A; Goldammer T; Rebl H; Korytář T; Köllner B; Yang W; Rebl A; Seyfert HM
Fish Shellfish Immunol; 2014 Jan; 36(1):206-14. PubMed ID: 24239597
[TBL] [Abstract][Full Text] [Related]
39. Novel approaches to targeting MYD88 in Waldenström macroglobulinemia.
Castillo JJ; Hunter ZR; Yang G; Treon SP
Expert Rev Hematol; 2017 Aug; 10(8):739-744. PubMed ID: 28617062
[TBL] [Abstract][Full Text] [Related]
40. Activating L265P mutations of the MYD88 gene are common in primary central nervous system lymphoma.
Montesinos-Rongen M; Godlewska E; Brunn A; Wiestler OD; Siebert R; Deckert M
Acta Neuropathol; 2011 Dec; 122(6):791-2. PubMed ID: 22020631
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
